Replies to post #100387 on Biotech Values

[DewDiligence]

Thanks, genisi. I was going to suggest that you repost this article on the CORX board, but then I saw that bladerunner already did. Regards, Dew

[DewDiligence]

FDA panel unanimously endorses GSK/VRX’s Potiga for reduction of epileptic seizures:

http://www.reuters.com/article/idCAN1115512120100811

[DewDiligence]

FDA approves GSK/VRX’s Potiga (ezogabine) for partial-onset epileptic seizures:

http://finance.yahoo.com/news/Valeant-and-GlaxoSmithKline-prnews-2921421643.html?x=0&.v=1

Potiga received an FDA CRL in Dec 2010 despite the fact that the advisory panel had unanimously backed approval in Aug 2010 (#msg-57275237).

In the EU, the drug was approved for marketing in Mar 2011 under the brand name, Trobalt.